The U.S. Food and Drug Administration (FDA) has approved the Xarelto Starter Pack for deep vein thrombosis (DVT) and/or pulmonary embolism (PE) treatment. The starter pack was designed to help simplify the dosing for the initial 30-day treatment period when patients are at greatest risk of having another DVT or PE.
